Clinical Trial Update: Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians [NA]

View source ↗

Summary

A clinical trial evaluating electronic interpretation training for Florbetapir F-18 PET imaging in Japanese physicians was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | NA | Status: WITHDRAWN